Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added location: Tainan, Taiwan, 704, and removed location: Tainan City, Taiwan, 704 from the study locations.
    Difference
    0.0%
    Check dated 2025-11-11T03:16:38.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed the related topic links for Head and neck squamous cell carcinoma and MedlinePlus Genetics from the page.
    Difference
    0.4%
    Check dated 2025-10-27T20:54:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic on head and neck squamous cell carcinoma to the page; no deletions were made. This expands core content with a credible medical resource.
    Difference
    0.3%
    Check dated 2025-10-20T17:12:18.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including potential delays in processing and inquiries. Core page reliability information has changed.
    Difference
    3%
    Check dated 2025-10-06T07:56:46.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Major change: introduction of Squamous cell carcinoma of the head and neck and a new version label v3.1.0, with removal of the prior related topic and older version.
    Difference
    0.7%
    Check dated 2025-09-29T04:22:49.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Adds a new MedlinePlus Genetics topic on Head and neck squamous cell carcinoma and updates the page revision from v3.0.1 to v3.0.2, while removing the 'Back to Top' UI element.
    Difference
    0.5%
    Check dated 2025-09-14T21:52:56.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.